Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease
characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the …

Chronic liver disease is a major cause of morbidity and mortality worldwide. Epidemiology,
clinical phenotype and response to therapies for gastrointestinal and liver diseases are …

Abstract Background and Aims Patients with primary biliary cholangitis (PBC) and
insufficient response to ursodeoxycholic acid (UDCA), currently assessed after 1 year, are …

Primary biliary cholangitis (PBC) is an immune-mediated cholestatic liver disease mainly
diagnosed in middle-aged women, with a female-to-male ratio between 4 to 5: 1 and 9 to 10 …

Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by the
production of diagnostic antimitochondrial antibodies (AMA) reactive to the pyruvate …

Primary biliary cholangitis (PBC) is an enigmatic, autoimmune disease targeting the small
intralobular bile ducts resulting in cholestasis and potentially progression to biliary cirrhosis …

Objectives The association between systemic lupus erythematosus (SLE) and primary biliary
cholangitis (PBC) has been increasingly recognized. However, the existence of causal …

ABSTRACT Indigenous Peoples in Canada face healthcare inequities impacting access to
solid organ transplantation. The experiences of Indigenous patients during the liver …

Background There are no longitudinal studies on the epidemiology of primary biliary
cholangitis (PBC) in Korea. This study aimed to elucidate the temporal trends in the …